The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
This is an oral abstract session about Components.
Learning Objectives:
Illustrate the use and safety of low titer group O whole blood transfusions in non-trauma clinical settings
Evaluate the degree of pathogen inactivation achieved and effects on storage lesion using a novel direct UVC light-only treatment of RBC units in additive solution
Describe the frequency of hemolysis or DAT positivity with use of low titer group O whole blood transfusions
Examine whether lack of the plasticizer DEHP affects the hematologic characteristics of whole blood and blood components during storage
Moderator(s):
Robert
DeSimone,
MD,
Director of Transfusion Medicine,
Weill Cornell Medicine
By completing the evaluation, you are attesting to watching the presentation in its entirety. A certificate will be immediately provided after submission.